Anebulo Pharmaceuticals, Inc. (ANEB) stock
ANEBNasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.00+0.00 (+75.00%)
Close on Oct 19, 2026Market cap $28.76KP/E –Yield –
Anebulo Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Anebulo Pharmaceuticals's cash was $9.04M at Dec 31, 2025. For fiscal 2025 it was $11.63M, up 275.8% from the year before. The highest annual figure on record is $19.99M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Jun 30, 2025 | $11.63M | +275.8% |
| FY2024 | Jun 30, 2024 | $3.09M | -72.5% |
| FY2023 | Jun 30, 2023 | $11.25M | -22.7% |
| FY2022 | Jun 30, 2022 | $14.55M | -27.2% |
| FY2021 | Jun 30, 2021 | $19.99M | +560.7% |
| FY2020 | Jun 30, 2020 | $3.02M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $9.04M | -39.7% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $10.35M | +637.4% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $11.63M | +275.8% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $13.28M | +158.0% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $15.00M | +125.7% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $1.40M | -83.5% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $3.09M | -72.5% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $5.15M | -63.7% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $6.64M | -59.4% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $8.52M | -55.7% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $11.25M | -22.7% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $14.16M | -14.4% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $16.36M | -9.2% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $19.21M | +0.0% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $14.55M | -27.2% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $16.55M | +400.4% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $18.01M | +495.3% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $19.21M | – |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $19.99M | – |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $3.31M | – |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $3.02M | – |
See a number that looks wrong?